Inhibition of miR-497 Reduces Oral Submucous Fibrosis
Author Information
Author(s): Huang Jie, Zhang Huang, Fan Xusheng, Guo Junxin
Primary Institution: Hangzhou First People’s Hospital Affiliated to Medical College of Zhejiang University
Hypothesis
This study aimed to evaluate the effect and detailed mechanism of miR-497 in arecoline-induced oral submucous fibrosis in buccal mucosal fibroblasts.
Conclusion
Inhibition of miR-497 may protect against oral submucous fibrosis by inhibiting myofibroblast transdifferentiation through the TGF-β1/Smads signaling pathway.
Supporting Evidence
- miR-497 inhibition suppressed the contractility, migration, and invasiveness of AR-induced buccal mucosal fibroblasts.
- Overexpression of miR-497 produced the opposite effects.
- miR-497 inhibition down-regulated the expression level of collagen I and α-SMA in AR-exposed buccal mucosal fibroblasts.
- TGF-β1 expression and Smad2 and Smad3 phosphorylation were repressed after miR-497 inhibition.
Takeaway
This study found that blocking a tiny molecule called miR-497 can help stop a disease that makes it hard to open your mouth by preventing certain cells from changing into a harmful form.
Methodology
The study involved silencing or overexpressing miR-497 in buccal mucosal fibroblasts and assessing contractility, migration, and invasiveness using various assays.
Limitations
Only one cell line was used, and the study lacked in-vivo experiments to validate the findings.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website